Respiratory failure & ventilation

Poor control of pulmonary viral replication in COVID-19 patients with early respiratory failure

Anaesth Crit Care Pain MedPublished Prospective cohort study

Authors' conclusion

At the time of IMV initiation, patients with early respiratory failure showed high levels of SARS-CoV-2 RNA and evidence of active viral replication in the lower respiratory tract.

Study context

Population
Critically ill COVID-19 patients requiring invasive mechanical ventilation (IMV); Bronchoalveolar lavage (BAL) collected within 24 h of intubation
Participants
159 patients
Outcome
SARS-CoV-2 detection and replication in BAL
Follow-up
Within 24 h of intubation
Methodological detailssub-study of the CIBERESUCICOVID project
  • Sub-study of the CIBERESUCICOVID project

Main finding

As reported in the abstract

SARS-CoV-2 RNA detected in BAL samples

84.3%

Positive for subgenomic E RNA

71.7%

Replication-competent virus confirmed

60%

Observational data: associations, not effects.

Further findings

Host immune gene expression

Marked suppression of innate immune effectors despite robust expression of type I and type III interferons
CXCL10 and PDL1 only genes independently associated with shorter time from symptom onset to IMV initiation

Original publication

Poor control of pulmonary viral replication in COVID-19 patients with early respiratory failure. Anaesth Crit Care Pain Med. Published 25 February 2026. doi:10.1016/j.accpm.2026.101779

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.